Loading...

CRO Solutions for Clinical Trials Across Asia-Pacific

Conducting clinical trials in Asia gives biotech and pharmaceutical sponsors access to diverse patient populations and accelerated development timelines.

CMIC Group provides end-to-end support for Asia-Pacific clinical trials, connecting sponsors with 4,000+ clinical sites while managing regional operations, regulatory submissions, and localized clinical services.

0+
Clinical sites connected
0+
APAC countries supported
0+
Studies completed in South Korea
0%
Of clients would choose CMIC again*

Why CMIC

Get to the Market Faster with CMIC’s Premier Asia-Pacific Clinical Trial Services

Is your goal to effectively introduce your product to the market? Do you need a single partner to support development, clinical trial services, commercialization, and more?

CMIC Group is a reliable partner for APAC clinical trials. As Japan’s largest CRO, we support trials across 12+ countries, with expertise in oncology, infectious diseases and vaccines, metabolic diseases, and neurology. As South Korea’s first CRO, we have completed 600+ studies, with oncology comprising 30%+ of our clinical programs.

See why 97% of our clients would choose CMIC again and recommend our services.*

Areas We Support

While these are just some of the areas we support, we are not limited, as we are a full-service clinical research organization with a dynamic range of expertise and resources at your disposal.

  • Registry Study
  • Observational Study
  • Phases II/III Clinical Trials
  • Phase IV Clinical Trials
  • Post-marketing Surveillance

Our Edge in Asia-Pacific Clinical Trials

Which CRO Should You Choose for Asia-Pacific Clinical Trials?

Choose a CRO with proven local expertise, regional reach, and the ability to manage complex regulatory and cultural differences across APAC markets. CMIC Group provides integrated clinical support across 12+ APAC countries, offering distinct operational advantages:

Proven Cost and Timeline Efficiencies

30% to 40% Lower Trial Costs: Emerging APAC markets can offer lower expenditures for procedures, diagnostic tests, and site visits compared with North America and Europe. (Source: Clinical Leader)

Bypass the 4-Year Timeline Penalty: Oncology trials average 12 years to reach approval globally, compared with eight years for non-oncology trials. Accessing APAC’s rapid start-up timelines is a pivotal strategy to bypass this development bottleneck. (Source: DIA Global Forum)

Highly Experienced CRAs & Organized Oversight

93% of surveyed clients rated CMIC CRAs as qualified and organized, and 97% of surveyed clients in Asia would choose to work with CMIC again¹.

Our locally based clinical research associates (CRAs) use standardized, multi-country monitoring SOPs, which actively minimize protocol deviations and protect data integrity across diverse clinical sites.

Appropriate Expertise and Compliance

CMIC oversees trial activities to support on-time, on-target delivery and maintains strong relationships with leading clinical trial centers.

100% of surveyed clients agree that CMIC project managers make a positive contribution to their studies, translating localized site logistics into structured timeline updates.

Broad Therapeutic Area Experiences

Over 30% of CMIC studies are in oncology, spanning solid and liquid tumors, with additional expertise in advanced therapies, biologics, medical devices, and cardiovascular studies.

For blood cancer trials, our partnership with National Cancer Center Japan supports targeted recruitment through HM-SCREEN-Japan, using real-time genomic mutation data to match patients to complex protocols.

CMIC clinical research team supporting Asia-Pacific trials

Regional Reach

Find an Asia-Pacific Clinical CRO Service Provider

You can find an Asia-Pacific clinical CRO service provider by looking for established regional networks operating across key hubs like Japan, South Korea, Taiwan, and Singapore. CMIC Group serves as a leading provider in this region, supporting trials in more than 12 countries. This coverage connects sponsors to 4,000+ clinical sites to streamline multi-country study startups.

 

Experienced Japan & South Korea Entry (ICCC Services)

CMIC serves as the In-Country Clinical Caretaker (ICCC) for foreign companies conducting clinical trials in Japan, supporting timely, high-quality, compliant, and quality-assured study delivery.

For overseas biotech organizations without a physical office, we act as your legal regulatory representative, supporting PMDA consultations and local trial compliance through to final marketing authorization.

Featured Report

The South Korean Clinical Trials Market: Citeline Scrip Asia 100 Report

CMIC Group was recently featured in Citeline’s “Scrip Asia 100 Report”. Access the free PDF to read our full-featured article.

HyeSook (Aviva) Park, Country Head of CMIC Korea, shares insights on South Korea’s growing role as a premier destination for global clinical research. With a strong regulatory framework, advanced infrastructure, and a skilled team, South Korea continues to attract international sponsors looking for high-quality, efficient, patient-focused trials. In this Q&A, Park discusses the country’s key advantages, recent regulatory developments, and how CMIC supports sponsors in navigating the Korean market.

Citeline Scrip Asia 100 Report cover

Integrated CRO Services

Why Partner With a CRO for Clinical Trials in The Asia-Pacific?

The Asia-Pacific region offers access to large, diverse patient populations, advanced research institutions, and growing clinical trial capabilities.

Sponsors evaluating APAC trials can leverage CMIC Group’s integrated CRO services, connecting regulatory planning, site logistics, and data management into a single operational pipeline:

Cohesive Study Management

Localized clinical operations and project management work in tandem. This structured oversight ensures on-time delivery, backed by a 100% client satisfaction rating for our regional project managers.

Rapid Site and Patient Access

We connect your program 4,000+ clinical sites across 12+ APAC countries, leveraging genomic networks like HM-SCREEN-Japan to accelerate targeted oncology recruitment.

Quality-Assured Compliance

Local regulatory experts streamline PMDA filings and multi-country monitoring SOPs to protect data integrity, with 93% of surveyed clients rating our CRAs as qualified and organized.

Phase & Therapeutic Versatility

We support clinical trials from early Phase I through Phase IV registries. Our therapeutic depth spans cardiovascular studies and oncology, which together constitute over 30% of CMIC’s portfolio.

Contact our APAC team or submit our contact form to discuss your program’s scope today.

Resources

Case Study: Seamless First-in-Human Oncology Trial Across the Globe
RAPS podcast featuring woman speaking at a mic.

  • [Podcast] Executive Insights on Accelerating Drug Development and Market Access in Japan & Asia-Pacific

    Podcasts

APAC Map with magnify glass showcasing where CMIC's Asia Pacific clinical trials are held

Have inquiries about our services or are you interested in outsourcing your operations to us?

Beyond the Trial

Launch-Ready Support for Asia-Pacific Clinical Trials

CMIC Group provides customized solutions to support post-approval adoption and regional market growth.

Commercial

  • Comprehensive Sales and Marketing Support
  • Human Resources Solutions for MR
  • Remote Communication Support
  • Training/Assessment

Medical Affairs

  • MA Consulting
  • Operational Support
  • Human Resources Solutions for MA/MSL
  • MA/MSL Training

Patient Solutions

  • Patient Support Programs
  • Nurse Educator

*Based on client survey responses from participating APAC markets; Japan not included.

Partner with CMIC Group Today

Maximize the probability of success for your clinical trial and accelerate your drug development timeline across APAC.

FAQ

Answers to Your Questions on Asia-Pacific Clinical Trial Development

Find answers to common questions about selecting a partner, managing regulatory compliance, and executing successful Asia-Pacific clinical trials.

Which companies offer clinical trial quality assurance in the Asia-Pacific region?

Several global and regional contract research organizations offer clinical trial quality assurance services in the Asia-Pacific. Partners like CMIC Group provide thorough audit, qualification, and data verification services aligned with international regulatory requirements. These robust quality systems ensure that clinical datasets collected during Asia-Pacific clinical trials are fully inspection-ready for agencies such as the FDA and PMDA.

To select a contract research organization for rare disease trials in APAC, you should evaluate its specific expertise in orphan drug development and local patient recruitment. Sponsors should choose a partner with proven experience in specialized therapies. It’s beneficial to select a CRO with strong relationships with medical centers since finding patients with rare diseases for Asia-Pacific clinical trials requires deep, localized investigator networks.

Experienced contract research organizations provide clinical trial project management services in the Asia-Pacific region. Among these providers, CMIC Group provides specialized regional oversight across multiple countries, leveraging highly qualified, localized clinical teams. This structured management supports the execution of your Asia-Pacific clinical trials, with 100% of surveyed clients agreeing that our project managers make a positive contribution to their studies.

¹ Clients surveyed did not include those from projects conducted in Japan.